Hybridomas, which produce monoclonal antibodies, are made by fusing cells of the immune system with B lymphocytes and myeloma cells.
<h3>
What are Hybridomas?</h3>
- Large-scale production of monoclonal antibodies is made possible through hybridoma technology.
- An antigen that triggers an immune response is first injected into a mammal to begin the process.
- A specific sort of white blood cell called a B cell makes antibodies that bind to the antigen that has been injected.
- These antibody-producing B-cells are then removed from the animal and combined with immortal B cell cancer cells, or myeloma, to create a hybrid cell line known as a hybridoma.
- It possesses both longevity and procreative capacity of the myeloma and the antibody-producing capacity of the B-cell.
Hence, the creation of hybridomas, which result in the production of monoclonal antibodies, involves fusing immune system cells with B lymphocytes and myeloma cells.
To learn more about Hybridomas refer to:
brainly.com/question/15189667
#SPJ4
The most crucial intervention is the UWSD Unit and tubing when turning a patient who has a right-sided hemothorax and 250 ml of dark blood streams into the chest tube container.
<h3>What should come first in the treatment of a patient with a chest tube?</h3>
Coughing, shifting positions often, and deep breathing encourage fluid drainage and lung expansion. Avoid forceful manipulation of the chest tube, such as stripping or milking, as this can lead to extremely negative pressures inside the tube and helps little to keep it open.
<h3>When a chest tube comes out, what should a nurse do?</h3>
Remain composed throughout an unexpected chest tube removal. Cover the open insertion site as soon as possible with a gloved hand, calling for assistance all the while remaining beside the patient. Request petroleum gauze, dry gauze, and tape to finish the dressing and cover the area.
To know more about Intervention visit:
brainly.com/question/2843028
#SPJ4
A systematic, rational method of planning and providing nursing care.